Precision medicine is no longer limited to targeted drug therapy; it has also been adopted in radiation therapy. In the past, radiation beams only matched the height and width of the tumor causing significant damage to the surround tissue. Advances in imaging technology have made it possible to locate and treat the tumor more precisely,…
Dr. Nicolette Rodriguez leads the REGENERATE study to find the best ways to get more Black and Latinx Americans genetic testing for cancer.
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.
Harry Schlechte had a Whipple procedure for his pancreatic cancer, but he credits his faith for getting him through treatment.
Dr. Diane Simeone and genetic counselor Jessica Everett explain why it is important to create a medical family tree for pancreatic cancer.
A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.
A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.
Although COVID-19 dominated the news, important new research and clinical trials began for pancreatic cancer patients.
An investigational drug is being used in an expanded access trial for advanced pancreatic and other cancer patients with specific genetic changes.